We are live on
!
Find out more
SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
62 hedge funds and large institutions have $72M invested in Sorrento Therapeutics, Inc. in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 16 increasing their positions, 19 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
2,025% more call options, than puts
Call options by funds: $170K | Put options by funds: $8K
5% more capital invested
Capital invested by funds: $68.3M → $72M (+$3.69M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less funds holding
Funds holding: 68 → 62 (-6)
16% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 19
60% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 10
Holders
62
Holders Change
-6
Holders Change %
-8.82%
% of All Funds
1.65%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
16
Reduced
19
Closed
10
Calls
$170K
Puts
$8K
Net Calls
+$162K
Net Calls Change
+$255K
Top Buyers
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$3.26M |
| 2 |
WCM
Wildcat Capital Management
New York
|
+$1.13M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$556K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$246K |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$164K |
